SCYX FY 2014 Earnings — SCYNEXIS, Inc. Revenue & Financial Results | Market Cap Arena

SCYXSCYNEXIS, Inc.

$38M

FY 2014 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$1M-92.5% YoY

Gross Profit

-$14M-1129.8% margin

Operating Income

-$15M-1166.2% margin

Net Income

-$4M-337.1% margin

EPS (Diluted)

$-7.13

Cash Flow

Operating Cash Flow

-$9M

Free Cash Flow

-$10M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$40M

Total Liabilities

$6M

Stockholders' Equity

$33M

Cash & Equivalents

$32M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1M	$17M	-92.5%
Gross Profit	-$14M	$552,000	-2670.7%
Operating Income	-$15M	-$7M	-103.3%
Net Income	-$4M	-$30M	+86.1%